首页 | 本学科首页   官方微博 | 高级检索  
     检索      

经尿道等离子体电切治疗前列腺增生
引用本文:周永兴,李力,李永林,陈锐永.经尿道等离子体电切治疗前列腺增生[J].大理学院学报,2005,4(3):39-40.
作者姓名:周永兴  李力  李永林  陈锐永
作者单位:泸西县人民医院泌尿外科,云南,泸西,652400
摘    要:目的:探讨治疗前列腺增生(BPH)的方法和疗效。方法:采用经尿道等离子体前列腺切除术(TUPKVP)治疗BPH32例。结果:术中出血少、无水中毒及尿失禁的发生,疗效满意。结论:TUPKVP是继经尿道前列腺电切术和经尿道前列腺电汽化术之后腔内治疗BPH的新疗法。该术式具有安全性高、易掌握、并发症少、疗效确切等优点。

关 键 词:前列腺增生  前列腺切除术  等离子体
文章编号:1672-2345(2005)03-0039-02
修稿时间:2005年3月3日

Transurethral Plasmakentic Vaporization of Prostate for Treatment of the Aged BPH Patients at High Risk
ZHOU Yong-xing,LI Li,LI Yong-lin et al.Transurethral Plasmakentic Vaporization of Prostate for Treatment of the Aged BPH Patients at High Risk[J].Journal of Dali University,2005,4(3):39-40.
Authors:ZHOU Yong-xing  LI Li  LI Yong-lin
Abstract:Objective: To discuss the efficacy of transurethraal plasmakentic vaporization of prostate (TUPKVP) for symptomatic benign prostatic hyperplasia (BPH) in the aged patients at high risk. Methods: 32 cases BPH patients at high risk were treated by TUPKVP. Results: The patients had less blood loss and no water intoxication happening during the operation and no incontinence occurring after the operation. Conclusions: TUPKVP is a new treatment for the BPH patient, especially for aged patients at high risk. It has the advantages of high safety, less complications and good efficacy.
Keywords:Prostatic hyperplasia  Transurethral prostatectomy  Plasmakentic
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号